The human dopamine transporter (DAT) gene contains a variable number tandem repeat (VNTR; 40 bases/3 to Ͼ11 repeats) in the 3Ј-untranslated region (3Ј-UTR), resulting in multiple alleles categorized by length. The 10-copy allele has been associated with attention deficit hyperactivity disorder (ADHD), yet it accounts for only a small proportion of symptom variance. We investigated whether the rhesus monkey DAT gene contains a repeat sequence similar to the human and whether this region differs in the five most hyperactive and the five most sedate animals selected from a behaviorally characterized cohort (n = 22). A fixed number tandem repeat (FNTR; 39 bases/12 repeats) was observed in all animals. Accordingly, this FNTR is unbefitting an association of DAT transcript length with hyperactivity. However, sequence analysis revealed potential single nucleotide polymorphisms (SNPs), one of which affects a Bst1107I restriction site. We screened the entire cohort, confirmed that all the rhesus monkeys had repeat regions of the same length, and demonstrated that digestion with Bst1107I was sufficient to distinguish two distinct FNTR alleles. Bst1107I genotype was suggestive but not predictive of hyperactive behavior. Based on these data, we speculated that SNPs may exist in human DAT VNTR alleles. To support this hypothesis, we cloned a portion of a novel 10-repeat allele from the human gene containing an SNP that abolishes a DraI restriction site. We conclude that SNPs create a diversity of DAT alleles between individuals that may be greater than previously identified based solely on the length of the VNTR region, and that alleles of specific sequence may contribute to dopamine-related disorders. Molecular Psychiatry (2001) 6, 50-58.
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The most consistent finding among this literature has been an association of a 10-copy allele with attention deficit hyperactivity disorder (ADHD). [17] [18] [19] [20] [21] [22] Although the pathophysiology of ADHD is not well understood, a significant focus of ADHD research has converged on the DAT. The DAT is a principal target of anti-hyperactivity medications in brain 23, 24 and is elevated in brains of a small sample of adults with ADHD compared with age-matched controls. 25 High transporter levels may arise from a number of processes, including dysfunctional regulation of DAT protein expression by the transporter gene.
Establishing a link between polymorphisms of the transporter and hyperactivity would be strengthened if a similar association existed in non-human populations. Although a species of spontaneously hypertensive rat displays hyperactivity and is considered a model for ADHD, [26] [27] [28] rats (and mice) do not contain analogous repeat sequences in the 3Ј-UTR of the DAT (Genbank: Gu et al, AF109072; Shimada et al, M80570). Accordingly, rodents are inappropriate for investigating the contribution of DAT alleles of a particular length to hyperactivity. In view of the evolutionary proximity of nonhuman primates to humans, we hypothesized that a repeat sequence in the DAT gene was more likely to appear in the nonhuman primate genome than in other species.
We initiated the present studies in rhesus monkeys to investigate whether a tandem repeat sequence was present in the 3Ј-UTR of the DAT gene, whether the number of repeat units varied between animals, and whether there was an association between the 3Ј-UTR of the DAT gene with hyperactivity in monkeys. In the absence of an established animal model of ADHD in non-human primates, we compared the five most hyperactive with the five most sedate animals from a behaviorally characterized cohort (n = 22). Similar to human but unlike other species previously studied, we found a fixed number tandem repeat (FNTR) sequence in the 3Ј-UTR of the monkey DAT gene. In contrast to the human gene sequence, the FNTR (39 bases/repeat and 12 repeats) is present in both hyperactive and sedate animals as well as other monkeys. Accordingly, this FNTR is unbefitting an association of DAT transcript length with hyperactivity. However, sequence analysis revealed potential single nucleotide polymorphisms (SNPs), one of which affects a Bst1107I restriction site. We screened the entire cohort, confirmed that all the rhesus monkeys had repeat regions of the same length, and demonstrated that digestion with Bst1107I was sufficient to distinguish two distinct FNTR alleles. Bst1107I genotype was suggestive but not predictive of hyperactive behavior. Based on these data, we speculated that SNPs may exist in human DAT VNTR alleles.
To support this hypothesis, we cloned a portion of a novel 10-repeat allele of the human DAT gene containing an SNP that abolishes a DraI restriction site. We conclude that SNPs create a diversity of DAT alleles between individuals that may be greater than previously identified based solely on the length of the VNTR region, and that alleles of specific sequence may contribute to dopamine-related disorders. Our findings provide a novel direction for investigating the role of the DAT gene in dopamine-related neuropsychiatric disorders, and in ADHD, in particular.
Materials and methods

Animal subjects
DNA was extracted from a total of 22 adult male rhesus monkeys (Macaca mulatta) of the New England Regional Primate Research Center colony. Twelve animals were born locally and ranged in age from 6-19 years. None of these animals were siblings. The other ten animals were at least 7 years old and were acquired from five different sources. Individually housed subjects were observed daily during normal work hours and scored by personnel unaware of subsequent molecular biology experiments. Ratings were based on observations made for one or more years (293.25 ± 9.8;
Molecular Psychiatry mean ± SEM, observations per animal, with the exception of subject No. 7 and No. 20 that were observed 49 times each; Table 1 ). Each monkey was observed once a day for a 5-min period using a modified frequency scoring system in which the presence or absence of 36 categories of behavior was noted in each of twenty 15-s intervals. Half the observations occurred in the morning between 0900-1030 h with the remainder in the afternoon between 1300-1430 h. Scores from each session were averaged and represent the number of times each category of behavior was observed within a rating session. Behaviors were recorded for general activity and self-directed activity (Table 1) . General activity was scored if the animal engaged in pacing, back flipping, rocking, and bouncing. Self-directed activity was scored if the monkeys engaged in self-biting, self-grasping, eye poking, hair pulling and digit sucking. Five monkeys that displayed the highest levels of general activity and variable levels of self-directed activity were designated hyperactive (4, 5, 2, 6 and 7; Table 1 ). Five monkeys that displayed a relatively low level of overall activity and self-directed activity were designated sedate (1, 3, 8, 9 and 10; Table 1 ). Grouping of the animals was based on hyperactivity scores, not on scores of self-directed behavior, which were generally higher in the hyperactive monkeys than in other subjects. Genomic DNA sample isolation Personnel who conducted the molecular biology procedures had no access to activity scores of the primate subjects. Genomic DNA is an appropriate source material for these studies because the majority of the 3Ј-UTR of the DAT, including the entire VNTR region, is represented by a single exon in human (exon 15, Genbank accession numbers D88570, U22502). Venous blood samples (10 ml) were collected in vacutainer® (Becton Dickinson, Franklin Lakes, NJ, USA) tubes containing EDTA and were stored at −80°C. Genomic DNA was isolated from 400 l whole blood using a 
Polymerase chain reaction
Oligonucleotide primers previously utilized for amplification of the human DAT VNTR 29 failed to amplify any reaction products from monkey genomic DNA samples. We therefore designed a series of novel primers, based on the human DAT sequence, and selected one set (U13: 5Ј TGTTCAGAGGCATTGGAG 3Ј; L12: 5Ј AAAAAGCCATTCGCAAACAT 3Ј) that gave consistent results in both monkey and human samples for PCR analysis and genotyping in the present study. A second set of primers (U10: 5Ј AGAAGGTGAAATGGAG GAAAC 3Ј; L13: 5Ј AGTGGCAGAGGGCAGTGT 3Ј) was utilized on human genomic DNA to yield a slightly larger PCR product that encompasses a DraI restriction site. A third set of primers (U13; L10: 5Ј ACACTGCCCTCTGCCACTGAC 3Ј) was utilized for cloning a larger fragment of the monkey DAT 3Ј UTR. 
Restriction endonuclease digestion
After cycling, PCR products were reserved or purified using a Qiaquick™ PCR clean-up kit (Qiagen, Valencia, CA, USA). Purified DNA was eluted in 15 l of RNasefree, DNase-free water (Sigma), and digested with 0.5 l of the restriction enzyme, Bst1107I (8-12 U l −1 ; Roche Molecular Biochemicals, Indianapolis, IN, USA) or 0.5 l DraI (10 U l −1 ; Roche Molecular Biochemicals) in a total volume of 20 l for 1-2 h at 37°C. Reserved and digested samples were loaded on 2.5% agarose gels containing ethidium bromide for electrophoresis at 120 V for 1 h. Gels were visualized and documented under UV transillumination.
DNA sequencing
Selected PCR products were subcloned into pcDNA3.1/V5/His-TOPO (InVitrogen, Carlsbad, CA, USA) using standard molecular biology techniques. Sequencing of both strands was performed on selected clones using a PE Applied Biosystem 373 automated DNA sequencer and Big dye dyeterminator cycle sequencing methodology according to the protocol of the manufacturer (Perkin-Elmer, Norwalk, CT, USA). The Molecular Biology Core Facilities, Dana Farber Cancer Institute, Boston, Massachusetts performed sequencing. Genbank accession numbers: AF287462 Macaca mulatta dopamine transporter 3Ј untranslated region, 12-repeat allele A. AF287463 Macaca mulatta dopamine transporter 3Ј untranslated region, 12-repeat allele B. AF287465 Homo sapiens dopamine transporter 3Ј untranslated region, DraI-sensitive 10-repeat allele. AF287466 Homo sapiens dopamine transporter 3Ј untranslated region, DraI-insensitive 10-repeat allele.
Results
Subject selection
Ten adult male rhesus monkeys of various ages were selected from a group of 22. The subjects were allocated into two groups, designated hyperactive and sedate, based on observations of general activity ( Table 1) . Nine of ten monkeys were observed from 228-362 times each and one monkey (No. 7) was observed 49 times. Each score is the mean of 292 ± 45 observations (mean ± SD; n = 9; No. 7 omitted). In the original group of 22 animals, total general activity scores averaged 2.62 ± 2.00 (mean ± SD; range: 0.015-7.82). Within this group, five monkeys displayed a higher level of activity than the other 17 animals (hyperactive: 5.27 ± 1.56; mean ± SD; range: 3.72-7.82; n = 5, others: 1.84 ± 1.34; mean ± SD; range: 0.015-3.68; n = 17, P = 0.002). Associated with hyperactivity was an increased incidence of self-directed activity in three of the five animals (1.84 ± 1.56, mean ± SD; n = 5), yielding overall scores (general activity and selfdirected activity) of 7.11 ± 1.52 (mean ± SD; n = 5; range: 4.46-8.89). These five monkeys were assigned to the hyperactive group. Within the group of 22 monkeys, another set of five monkeys displayed low scores for total general activity (sedate: 0.072 ± 0.054, mean ± SD; n = 5: range: 0.023-0.142) which were statistically different from the hyperactive group (P Ͻ 0.0001). The scores of self-directed activity (0.54 ± 0.17, mean ± SD; n = 5; range: 0.354-0.816) were lower than those in the hyperactive group (P = 0.122, NS), but two hyperactive monkeys also had relatively low levels of self-directed behavior ( Table 1) . The five sedate animals (overall scores, general activity and self-directed activity: 0.565 ± 0.194, mean ± SD; n = 5) were assigned to the sedate group based on statistical analysis of the scores.
Polymerase chain reaction products from rhesus monkey genomic DNA All rhesus monkey genomic DNA samples yielded a single visually detectable PCR amplification product. Data generated using primers U13 and L12 are shown (Figure 1) . In all cases, amplification products derived from the human genomic DNA pools had two visually detectable bands that migrated near an expected size Molecular Psychiatry of 697 bp and 657 bp, corresponding to ten-repeat and nine-repeat alleles (the most common alleles across human populations), respectively (data not shown). Despite the striking difference in behavioral profiles for hyperactive vs sedate monkeys (Table 1) , no differences in the size of the product from the two sets of monkeys were detectable.
Sequence analysis of DAT 3Ј-UTR sequence derived from rhesus monkeys
A comparison of sequence data of the DAT 3Ј-UTR obtained from a rhesus monkey and a human clone reveals robust sequence homology (Figure 2 ). Similar to human but not to other species, the rhesus monkey DAT 3Ј-UTR contains a tandem repeat sequence. Whereas each human repeat unit contains 40 bp, the rhesus sequence consists of twelve 39-bp repeat units. The repeat region has unique identity to the DAT gene (by NCBI BLAST). Each repeat has a unique sequence variation resulting in 21/39 bases (53.8%) conserved between all repeats (Table 2) .
We also observed six single base sequence variations between two rhesus monkey clones, suggesting that single nucleotide polymorphisms may be present in the monkey DAT 3Ј-UTR. One of these positions, (T or G) 576 (Figure 2 ) in repeat 12 (Table 2) , coincided with the first base of a Bst1107I endonuclease restriction enzyme recognition sequence, GTA/TAC, in one of the two clones. When present, this recognition sequence occurs only at this position, and since it was not present in both monkey sequences, digestion of the PCR products with this enzyme could distinguish G576 from T576 alleles in the cohort.
Bst1107I digestion of polymerase chain reaction products
We predicted from sequence analysis that restriction endonuclease digestion with Bst1107I would reveal two alleles of the fixed-length 3Ј-UTR of the rhesus monkey DAT gene. Reamplification and Bst1107I digestion of the PCR products from all 22 rhesus monkeys in the study was carried out. All 22 monkeys had a PCR product of the same size (data not shown). Restriction enzyme digestion revealed that each monkey was either homozygous for a Bst1107I-sensitive allele (Bst+/+), homozygous for a Bst1107I-insensitive allele (Bst−/−) or heterozygous (Bst+/−) (Figure 3) . Within the group of hyperactive (H) monkeys, four of the five hyperactive monkeys were Bst+/+, one was Bst+/− and none was Bst−/− (Figure 4) . Of the sedate (S) monkeys two were Bst+/+, two were Bst+/− and one was Bst−/−. Using a chi-square analysis, differences between the small groups were not statistically significant.
Identification of a novel 10-repeat human DAT allele
Based on our observation that the rhesus monkey FNTR had single nucleotide polymorphisms in the 3Ј untranslated region of the DAT, we hypothesized that human sequences may also contain single nucleotide polymorphisms in DAT alleles. A comparison of genbank sequences (AI768774, AI375850, and M95167) revealed a DraI single nucleotide polymorphism at position 3255 (position based on Genbank accession number S46955) which identifies a TTTA(A/T)A motif. Genbank entry AI768774 is an NCICGAPKid12 Homo sapiens cDNA clone (IMAGE:2403505), similar to gb:M95167 SODIUM-DEPENDENT DOPAMINE TRANSPORTER. The clone is derived from two pooled kidney tumors. It contains a TTTATA motif at the analogous position, rather than the TTTAAA motif present in other DAT clones in Genbank. The recognition sequence for DraI is TTT/AAA.
Using a pooled human genomic DNA sample (from Sigma), we amplified a portion of the human DAT 3Ј-UTR using the U10/L13 primer set to get a longer PCR product that encompassed the DraI recognition sequence (965 bases). DraI treatment resulted in an incomplete digestion of the PCR product. The undigested band was cloned and sequenced, resulting in isolation of a portion of the 3Ј-UTR of a DraI-insensi- Table 1 . Arrows show the genotype of sedate animals that have very low general activity.
tive human DAT allele. The sequence of our clone revealed a novel T784C (TCTAAA) DraI-insensitive polymorphism (position based on Genbank accession number AF287466).
Discussion
The present study had four objectives. First, we determined whether a tandem repeat region previously Figure 4 Restriction endonuclease digestion of PCR products with Bst1107I for the five most hyperactive and the five most sedate monkeys and a graphical summary of Bst1107I genotypes.
Molecular Psychiatry identified in human, but not in rodent, was present in the 3Ј-UTR of the monkey DAT gene. Our second objective was to determine whether the length of the repeat region, which varies in human subjects, also varies in monkeys. Third, we investigated whether the sequence of the repeat region in the monkey DAT gene varied between animals. Finally, we explored the relevance of these findings to hyperactivity in monkeys. Similar to humans and unlike rodents, the monkey DAT gene contains a FNTR, which is one base shorter per repeat than the VNTR in the human DAT gene. In contrast to the VNTR in the human DAT gene, which varies in length from 3 to Ͼ11 copies, the FNTR in the monkey DAT gene contains 12 repeats. Consequently, a relationship between the number of repeat sequences in the monkey DAT gene (the length of the 3Ј-UTR) and hyperactivity was not attainable. Although sequence analysis of alleles is not routinely used in searching for an association between specific DAT gene alleles and neuropsychiatric disorders, we investigated the 3Ј-UTR further. Sequence analysis revealed six single nucleotide differences between two clones. One of these differences coincided with a Bst1107I endonuclease restriction enzyme recognition sequence, providing us with a lead and an assay for determining whether the rhesus monkeys had different alleles of fixed length. We screened the entire cohort, confirmed that all the rhesus monkeys had repeat regions of the same length, and demonstrated that digestion with Bst1107I could clearly distinguish two distinct FNTR alleles. Bst1107I genotype was suggestive but not predictive of hyperactive behavior. On the basis of these findings in the rhesus monkey, we hypothesized that the 3Ј-UTR of the human DAT gene may also differentiate into unique subgroups of alleles based on single nucleotide polymorphisms rather than length of the VNTR. Following this lead, we discovered a novel DraI-insensitive SNP in the 10-repeat allele of the human DAT gene. Accord-ingly, the DAT gene may be more variable than previously detected, and may account for a greater proportion of the variance in symptoms of dopaminerelated disorders than has been appreciated. Our findings provide a novel direction for investigating of the role of the DAT gene in dopamine-related neuropsychiatric disorders, and in ADHD, in particular.
ADHD affects approximately 4% of children in the United States, and may persist into adulthood. 30 Among the proteins in human brain implicated in ADHD, 24, 31, 32 the DAT is a plausible candidate for investigation. The transporter is a principal target of the most widely used medications for treating ADHD 23, 24, 33 and is elevated in brains of a small sample of adults with ADHD compared with age-matched controls. 25 Anomalies in non-coding regions of the human DAT gene may be relevant to elevated DAT levels in adults with ADHD. Within the 3Ј-UTR, genotypes with the 10-repeat VNTR polymorphism 4, 5 are positively associated with ADHD. [17] [18] [19] [20] [21] Although the 10-repeat VNTR accounts for a small proportion of the variance in hyperactive children or family members, 19 the association is consistent in five [17] [18] [19] [20] [21] of six studies.
22
These results are conspicuously different from negative or inconsistent evidence linking VNTR alleles of the DAT gene with other neuropsychiatric disorders. [6] [7] [8] [9] [10] [11] [12] 14, 15, [34] [35] [36] Dysfunctional regulation of DAT protein expression by the 3Ј-UTR of the DAT gene may be one process of many which may account for putative elevated levels of DAT in ADHD. Evidence that polymorphic variants of the DAT may differentially affect DAT protein levels was recently reported. The 10-repeat/10-repeat genotype, which is most common in ADHD as well as the general population, had mean DAT protein levels in putamen that were 22% higher than individuals with the 9-repeat/10-repeat genotype, as determined by single photon emission computed tomography. 37 Within the family of monoamine transporters, a VNTR in the noncoding region of the serotonin transporter gene reportedly acts as a transcriptional regulatory element. 38 In a broader context, VNTR sequences can act as transcriptional, translational, and functional regulators of mRNA or structural modifiers of protein. 39 The present study investigated whether an association between DAT polymorphisms and hyperactivity extended to non-human primates. Although a species of rat that displays hyperactivity has been investigated as a model for ADHD, 26-28 rodents were not considered for this study because they do not contain analogous repeat sequences in the 3Ј-UTR of the DAT gene (Genbank: Gu et al, AF109072; Shimada et al, M80570). High levels of activity, a crucial symptom of ADHD in humans, were found in a subset of the monkeys observed for at least one year in our colony. The monkeys were markedly more active than relatively sedate animals used for comparative purposes. The incidence of self-directed activity was also higher in this cohort, although for two of five subjects, occurrences were similar or fewer than the sedate animals ( Table 1) .
Detection of the monkey DAT FNTR required the design of a new set of primers that differed from the primers used to detect the VNTR in the human gene. A previous unsuccessful search to detect this repeat region in rhesus monkey DNA may be attributable to the primers used in that study. 40 In contrast with the human sequence data, the comparable 3Ј-UTR of rhesus monkeys (n = 22) was of a fixed length and of twelve repeat sequences. We believe our sample size to be sufficient for this conclusion, as it is based not only on the present study, but on a consistent and invariant PCR product of the same size in 17/17 squirrel monkeys (Genbank: Miller et al, AF287464), and a very low level of variation (frequency of the most common allele greater than 0.95) among baboons, Papio hamadryas (personal communication, Jeffrey Rogers, Southwest Foundation).
Analysis of genomic DNA isolated from five hyperactive monkeys and five sedate monkeys revealed an identical length (number of repeats) of the 3Ј-UTR of the DAT gene for both groups of animals. Using an identical procedure, we readily identified nine and ten repeat copies of the DAT gene VNTR in the human control samples. Accordingly, it was not feasible to develop a relationship between the length of the tandem repeat region and hyperactivity in monkeys. However, a comparison of the DNA sequences of the 3Ј-UTR of the monkey DAT gene from two clones revealed six single base variations, one of which was detectable with restriction endonuclease (Bst1107I) digestion of the DNA. This novel single nucleotide polymorphism clearly differentiated two alleles of the same size in the monkeys. Four of five hyperactive monkeys had a Bst+/+ genotype, whereas only two of five sedate monkeys had this genotype (Figure 4) . It is important to note, however, that our data suggest the possibility of as many as six polymorphic variants of the FNTR region in rhesus monkeys. Hence, we may be grouping together multiple Bst1107I-sensitive (or -insensitive) alleles for our analysis of relation to hyperactivity. Perhaps this is why our assessment of genotype with this criteria was suggestive but not predictive of hyperactive behavior. Likewise, a similar confound may explain why the significant association of the human DAT 10-repeat allele with ADHD accounts for only a small proportion of symptom variance.
Based on these findings, we hypothesized that single nucleotide polymorphisms in the 3Ј-UTR of the human DAT may differentiate distinct alleles of the 10-repeat length (or another) allele. This hypothesis is supported by a G2319A single base polymorphism recently identified in the 10-repeat allele of the human DAT, 16 as well as 10 novel sequence variants in the human serotonin transporter linked polymorphism (5-HTTLPR) which were first thought to be only two (short and long) alleles. 41 Therefore, a majority of investigations that have attempted to associate DAT alleles, based on length, with dopamine-related disorders may be confounded by the grouping together of multiple alleles. Hence, the DAT gene may account for a greater proportion of the variance in symptoms of dopamine-related disorders than has been previously appreciated. To further support this hypothesis, we cloned a portion of the 3Ј-UTR of a 10-repeat allele of the human DAT gene from pooled human genomic DNA. Differential restriction endonuclease digestion of the PCR product discerned a novel variant of the 10-repeat allele that contains a DraI-insensitive SNP. The frequency of occurrence of this and other SNPs in 10-repeat alleles, and the relationship of these and other alleles to various neuropsychiatric disorders, awaits further study.
Alternatively, other factors may contribute to ADHD in humans and hyperactivity in monkeys. Genes encoding other dopaminergic proteins, such as the D 4 dopamine receptor, [42] [43] [44] [45] may be prominent contributors to hyperactivity in monkeys. The hyperactivity observed in this set of primates may not reflect the hyperactivity characteristic of human ADHD. Human ADHD is characterized primarily by the co-existence of attentional problems and hyperactivity, with each behavior occurring infrequently alone. 30 Monkey hyperactivity may not embody the dual characteristics of ADHD and arise from a different biological origin. Furthermore, the animals in this study were mature adults, whereas only a portion of children with ADHD retain symptoms into adulthood. 30 Accordingly, hyperactivity in adult monkeys may not represent the population of children and family members that were tested for polymorphisms. Finally, hyperactivity in adult monkeys may arise from different biological processes (eg, hyperthyroidism). 46 Polymorphisms in genes of other monoamine transporters or proteins in brain, 47 particularly norepinephrine, may contribute to hyperactivity in humans 32 and in nonhuman primates. For example, the noradrenergic-rich locus coeruleus may play a significant role in attentional modulation and the regulation of goal-directed behaviors in primates. 48, 49 The serotonin transporter has also been proposed to contribute to the antihyperactivity effects of methylphenidate, 50 but the low affinity of methylphenidate for the serotonin transporter is inconsistent with this hypothesis. 51 In summary, the present study revealed a distinct similarity in a portion of the 3Ј-UTR of monkey and human DAT genes that is not present in mouse or rat. This finding highlights the validity of using primates for research in DAT regulation and possibly other neuropsychiatric disorders that may exhibit a genetic component. Validation of this or other models of hyperactivity in nonhuman primates could accelerate understanding of the neurobiological basis of ADHD in humans. ADHD is of particular interest because of its high incidence in children, inheritability, controversy on under-or over-diagnosis and the potential consequences of long-term drug therapy. A primate model for ADHD awaits alignment of primate data with clinical data arising from neuropsychological, molecular, pharmacological and brain imaging research. Nevertheless, the similarities of the DAT gene in monkeys and humans, but not rodents, further supports the use of nonhuman primates as models for investigating the molecular basis of neuropsychiatric diseases and Molecular Psychiatry addiction to psychostimulants. The present study also demonstrated that single nucleotide polymorphisms can create a diversity of alleles of common length between individuals within the untranslated region of the dopamine transporter gene. This finding raises an intriguing and unanswered question: Can specific SNPs in the 3Ј-UTR of the dopamine transporter gene contribute to dysfunctional regulation of DAT protein levels in the brain? Previous attempts to associate DAT alleles with dopamine-related disorders were based solely on analysis of length. Accordingly, results may be confounded by the grouping together of multiple alleles of variable sequence. Our data suggest that the untranslated region of the DAT gene may be more variable than assumed. The functional significance of this variance is not known, but other reports have highlighted that sequence variations in the untranslated region may result in differential levels of gene expression. Dopamine transporter alleles of specific sequence such as those detected in the present study may lead to dysfunctional levels of DAT expression in the brain and contribute to dopamine-related disorders. Our findings in non-human primates provide a novel direction for investigating the role of the human DAT gene in dopamine-related neuropsychiatric disorders, and in ADHD, in particular.
